
Agfa-Gevaert Investor Relations Material
Latest events

Q2 2025
Agfa-Gevaert
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Agfa-Gevaert NV
Access all reports
Agfa-Gevaert NV (AGFB) is a company active in design, manufacturing, and marketing of imaging systems and products. The company operates in several key sectors, with its business activities segmented into Offset Solutions, Radiology Solutions, Digital Print & Chemicals, and HealthCare IT. In the Offset Solutions sector, Agfa-Gevaert is a primary supplier to the printing industry, offering a broad range of integrated solutions that include everything from computer-to-plate systems and digital offset plates to workflow optimization software and pressroom chemicals. The Radiology Solutions segment provides hospitals worldwide with traditional and digital radiography equipment, as well as image processing software. The Digital Print & Chemicals sector caters to sign & display printing companies with wide-format inkjet printers, inks, workflow software, cutting machines, and media, alongside classic film-based products for various industrial applications. Lastly, the HealthCare IT division delivers comprehensive solutions across Imaging IT, Hospital IT, and Integrated Care, aiming to enhance healthcare delivery by improving data management, diagnostic imaging, and patient care coordination. Agfa-Gevaert NV is headquartered in Mortsel, Belgium, and its shares are listed on the Euronext Brussels.
Key slides for Agfa-Gevaert NV


Q1 2025
Agfa-Gevaert NV


Q1 2025
Agfa-Gevaert NV
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
AGFB
Country
🇧🇪 Belgium